01
Cash & equivalents increased 20.9%
Cash & equivalents changed +20.9% from the comparable as-filed period.
$104.2M→$125.9MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTKodiak Sciences Inc.'s latest supported as-filed period reports net income of -$65.6M, 20.9% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +20.9% from the comparable as-filed period.
Net income changed -20.9% from the comparable as-filed period.
Operating income changed -20.4% from the comparable as-filed period.
Research & development changed +31.2% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
KOD · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-349251SEC ↗8-KAug 13, 2026Period Aug 13, 20260001193125-26-349107SEC ↗4Jul 17, 2026Period Jul 15, 20260001754045-26-000008SEC ↗4Jul 17, 2026Period Jul 15, 20260001754181-26-000011SEC ↗4Jul 2, 2026Period Jun 30, 20260001334505-26-000002SEC ↗4Jul 2, 2026Period Jun 30, 20260001143732-26-000002SEC ↗4Jul 2, 2026Period Jun 30, 20260001454983-26-000006SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 15, 2026Filed Jul 17, 2026 | BORGESON JOHN A.Chief Financial Officer | Grant Or AwardDirect | 66,500 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed -25.8% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001591312-26-000006